---
id: CVE-2025-61940
title: >-
  NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user
  account to access data in the database
summary: >-
  NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user
  account to access data in the database. User access in the client application
  is restricted by a password authentication check in the client software but
  the unde…
severity: high
cvss: 8.3
cvssVector: 'CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L'
cwe:
  - CWE-603
vendor: mirion
product: biodose/nmis
affected:
  - biodose/nmis < 23.0
patched:
  - biodose/nmis 23.0
published: '2025-12-02'
updated: '2026-09-25'
sourceUpdated: '2026-09-25T23:10:00.463'
source: NVD
sourceUrl: 'https://nvd.nist.gov/vuln/detail/CVE-2025-61940'
references:
  - url: 'https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01'
    label: ics-cert@hq.dhs.gov
tags:
  - nvd
epss: 0.00323
epssPercentile: 0.22842
ingestedAt: '2026-09-25T23:21:16.866Z'
---

## Overview

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.

## Affected

- `biodose/nmis < 23.0`

## Remediation

Upgrade past the affected range:

- `biodose/nmis 23.0`